MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ITRM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Iterum Therapeutics (ITRM) Ownership - Who owns Iterum Therapeutics?

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
Fitzwilliam Court
Phone
+353 16694820
Employees
14
Web
https://www.iterumtx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
9.05M
P/E Ratio
N/A
Total Cash
11M
Projected Growth
N/A
Total Debt
33.74M
Revenue
390K
Risk (Beta)
4.86
Dividend Yield
N/A
Total Cash/Share
0.21
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for ITRM
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
Fitzwilliam Court
Phone
+353 16694820
Employees
14
Web
https://www.iterumtx.com